TEM
Tempus AI, Inc. Class A Common Stock
About: Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Employees: 2,400
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
397% more first-time investments, than exits
New positions opened: 164 | Existing positions closed: 33
162% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 29
114% more funds holding in top 10
Funds holding in top 10: 7 [Q4 2024] → 15 (+8) [Q1 2025]
83% more funds holding
Funds holding: 155 [Q4 2024] → 284 (+129) [Q1 2025]
69% more call options, than puts
Call options by funds: $582M | Put options by funds: $344M
63% more capital invested
Capital invested by funds: $1.75B [Q4 2024] → $2.85B (+$1.11B) [Q1 2025]
1.43% more ownership
Funds ownership: 33.92% [Q4 2024] → 35.35% (+1.43%) [Q1 2025]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$60
16%
downside
Avg. target
$67
7%
downside
High target
$70
2%
downside
5 analyst ratings
3 positive
60%
2 neutral
40%
0 negative
0%
B of A Securities Michael Ryskin | 5%downside $68 | Neutral Maintained | 20 May 2025 |
Piper Sandler David Westenberg | 2%downside $70 | Neutral Maintained | 15 May 2025 |
Morgan Stanley Tejas Savant | 9%downside $65 | Overweight Maintained | 9 May 2025 |
Needham Ryan MacDonald | 2%downside $70 | Buy Reiterated | 7 May 2025 |
BTIG Mark Massaro | 16%downside $60 | Buy Initiated | 21 Apr 2025 |
Financial journalist opinion
Based on 108 articles about TEM published over the past 30 days
Neutral
GlobeNewsWire
1 day ago
TEMPUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Tempus AI, Inc. and Encourages Investors to Contact the Firm
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ: TEM) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Tempus securities between August 6, 2024 and May 27, 2025, both dates inclusive (the “Class Period”). Investors have until August 11, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Neutral
GlobeNewsWire
1 day ago
TEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Tempus AI, Inc. Class Action
SAN DIEGO, June 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025. Tempus purports to be provide Artificial Intelligence ("AI") enabled precision medicine solutions.
Neutral
GlobeNewsWire
1 day ago
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. (NASDAQ: TEM) resulting from allegations that Tempus AI may have issued materially misleading business information to the investing public.
Neutral
GlobeNewsWire
1 day ago
Shamis & Gentile, P.A. Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Tempus AI, Inc. and Sets a Lead Plaintiff Deadline of August 12, 2025
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Shamis & Gentile, P.A: To: All persons or entities who purchased or otherwise acquired Tempus AI, Inc. (“Tempus” or the “Company”) (NASDAQ:TEM) common stock between August 6, 2024 and May 27, 2025, inclusive. You are hereby notified that the class action lawsuit Shouse v.
Positive
Zacks Investment Research
1 day ago
Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach
TEM expands major partnerships with AZN, ILMN, and PSNL, fueling AI-driven R&D and widening its precision medicine reach.
Neutral
Accesswire
1 day ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Tempus AI, Inc.("Tempus" or the "Company") (NASDAQ:TEM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
PRNewsWire
2 days ago
Shareholder Alert: Robbins LLP Informs Investors of the Tempus AI, Inc. Class Action
SAN DIEGO , June 13, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025. Tempus purports to be provide Artificial Intelligence ("AI") enabled precision medicine solutions.
Neutral
Schaeffers Research
2 days ago
These 24 Stocks Are Ripe for a Short Squeeze
With the way negative stock market sentiment has piled up recently, short squeezes have generated some massive returns.
Neutral
Accesswire
2 days ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tempus AI, Inc. (TEM) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ:TEM). Investors who purchased Tempus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TEM.
Neutral
PRNewsWire
2 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
NEW YORK , June 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tempus AI, Inc. ("Tempus" or the "Company") (NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Charts implemented using Lightweight Charts™